📣 VC round data is live. Check it out!
- Public Comps
- Dr. Soliman Abdul Kader
Dr. Soliman Abdul Kader Valuation Multiples
Discover revenue and EBITDA valuation multiples for Dr. Soliman Abdul Kader and similar public comparables like Huaxia Eye Hospital Group, Acadia Healthcare, Select Medical, Topchoice Medical and more.
Dr. Soliman Abdul Kader Overview
About Dr. Soliman Abdul Kader
Dr Soliman Abdul Kader Fakeeh Hospital Co is a company whose principal activities include managing, establishing, and operating hospitals, clinics, medical, educational, and training centers. In addition to the above, the company is also managing and operating medical services, analysis and radiology laboratory, and managing and establishing pharmacies, wholesale and retail of medical equipment, maintenance of IT equipment, and software-related services. The group has three reportable segments, including medical services, which generates maximum revenue, education, trading, retail, and others. Geographically, it principally operates in the Kingdom of Saudi Arabia.
Founded
1978
HQ

Employees
2.7K
Website
Sectors
Financials (LTM)
EV
$2B
Valuation Multiples
Start free trialDr. Soliman Abdul Kader Financials
Dr. Soliman Abdul Kader reported last 12-month revenue of $859M and EBITDA of $143M.
In the same LTM period, Dr. Soliman Abdul Kader generated $195M in gross profit, $143M in EBITDA, and $75M in net income.
Revenue (LTM)
Dr. Soliman Abdul Kader P&L
In the most recent fiscal year, Dr. Soliman Abdul Kader reported revenue of $749M and EBITDA of $146M.
Dr. Soliman Abdul Kader is profitable as of last fiscal year, with gross margin of 25%, EBITDA margin of 20%, and net margin of 10%.
Financial data powered by Morningstar, Inc.
Dr. Soliman Abdul Kader Stock Performance
Dr. Soliman Abdul Kader has current market cap of $2B, and enterprise value of $2B.
Market Cap Evolution
Dr. Soliman Abdul Kader's stock price is $9.58.
Dr. Soliman Abdul Kader share price decreased by 1.4% in the last 30 days, and by 11.7% in the last year.
Dr. Soliman Abdul Kader has an EPS (earnings per share) of $0.34.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $2B | -0.7% | -1.4% | 6.1% | -11.7% | $0.34 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialDr. Soliman Abdul Kader Valuation Multiples
Dr. Soliman Abdul Kader trades at 2.8x EV/Revenue multiple, and 17.0x EV/EBITDA.
EV / Revenue (LTM)
Dr. Soliman Abdul Kader Financial Valuation Multiples
As of June 2, 2026, Dr. Soliman Abdul Kader has market cap of $2B and EV of $2B.
Dr. Soliman Abdul Kader has a P/E ratio of 29.4x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Dr. Soliman Abdul Kader Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Dr. Soliman Abdul Kader Margins & Growth Rates
Dr. Soliman Abdul Kader grew revenue by 10% but EBITDA decreased by 10% in the last fiscal year.
In the most recent fiscal year, Dr. Soliman Abdul Kader reported gross margin of 25%, EBITDA margin of 20%, and net margin of 10%.
Dr. Soliman Abdul Kader Margins
Dr. Soliman Abdul Kader Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Dr. Soliman Abdul Kader Operational KPIs
Dr. Soliman Abdul Kader's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.0M for the same period.
Dr. Soliman Abdul Kader's Rule of 40 is 28% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Dr. Soliman Abdul Kader's Rule of X is 43% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Dr. Soliman Abdul Kader Competitors
Dr. Soliman Abdul Kader competitors include Huaxia Eye Hospital Group, Acadia Healthcare, Select Medical, Topchoice Medical, Guardian Pharmacy Service, MLP Sağlık, Astrana Health, Akdital, Draegerwerk and Pediatrix.
Most Dr. Soliman Abdul Kader public comparables operate across Hospitals & Clinics.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 2.9x | 2.8x | 12.5x | 13.1x | |||
| 1.4x | 1.4x | 7.6x | 7.7x | |||
| 0.9x | 0.9x | 9.4x | 9.9x | |||
| 5.9x | 5.6x | 18.3x | 17.8x | |||
| 1.7x | 1.7x | 21.3x | 20.6x | |||
| 1.7x | 1.5x | 5.3x | 5.5x | |||
| 0.8x | 0.7x | 12.0x | 10.6x | |||
| 4.4x | 3.7x | 14.8x | 13.3x | |||
This data is available for Pro users. Sign up to see all Dr. Soliman Abdul Kader competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Dr. Soliman Abdul Kader
| When was Dr. Soliman Abdul Kader founded? | Dr. Soliman Abdul Kader was founded in 1978. |
| Where is Dr. Soliman Abdul Kader headquartered? | Dr. Soliman Abdul Kader is headquartered in Saudi Arabia. |
| How many employees does Dr. Soliman Abdul Kader have? | As of today, Dr. Soliman Abdul Kader has over 2K employees. |
| Is Dr. Soliman Abdul Kader publicly listed? | Yes, Dr. Soliman Abdul Kader is a public company listed on Tadawul. |
| What is the stock symbol of Dr. Soliman Abdul Kader? | Dr. Soliman Abdul Kader trades under 4017 ticker. |
| When did Dr. Soliman Abdul Kader go public? | Dr. Soliman Abdul Kader went public in 2024. |
| Who are competitors of Dr. Soliman Abdul Kader? | Dr. Soliman Abdul Kader main competitors include Huaxia Eye Hospital Group, Acadia Healthcare, Select Medical, Topchoice Medical, Guardian Pharmacy Service, MLP Sağlık, Astrana Health, Akdital, Draegerwerk, Pediatrix. |
| What is the current market cap of Dr. Soliman Abdul Kader? | Dr. Soliman Abdul Kader's current market cap is $2B. |
| What is the current revenue of Dr. Soliman Abdul Kader? | Dr. Soliman Abdul Kader's last 12 months revenue is $859M. |
| What is the current revenue growth of Dr. Soliman Abdul Kader? | Dr. Soliman Abdul Kader revenue growth (NTM/LTM) is 14%. |
| What is the current EV/Revenue multiple of Dr. Soliman Abdul Kader? | Current revenue multiple of Dr. Soliman Abdul Kader is 2.8x. |
| What is the current EBITDA of Dr. Soliman Abdul Kader? | Dr. Soliman Abdul Kader's last 12 months EBITDA is $143M. |
| What is Dr. Soliman Abdul Kader's EBITDA margin? | Dr. Soliman Abdul Kader's last 12 months EBITDA margin is 17%. |
| What is the current EV/EBITDA multiple of Dr. Soliman Abdul Kader? | Current EBITDA multiple of Dr. Soliman Abdul Kader is 17.0x. |
| How many companies Dr. Soliman Abdul Kader has acquired to date? | Dr. Soliman Abdul Kader hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Dr. Soliman Abdul Kader has invested to date? | Dr. Soliman Abdul Kader hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Dr. Soliman Abdul Kader
Lists including Dr. Soliman Abdul Kader
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.